Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies

Journal of Surgical Oncology

Volumn 101, Issue 6, 2010, Pages 507-512

  Fotopoulou, Christina ^a   Neumann, Ulf ^a   Kraetschell, Robert ^a   Schefold, Joerg C ^a   Weidemann, Henning ^a   Lichtenegger, Werner ^a   Sehouli, Jalid ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Gynecological malignancies; Morbidity; Pelvic exenteration; Radical surgery; Survival

Indexed keywords

CEPHALOSPORIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE;

ABSCESS; ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; CANCER RELAPSE; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COLOSTOMY; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; HUMAN; ILEUS; INCISIONAL HERNIA; INTESTINE FISTULA; INTRACARDIAC THROMBOSIS; IRRADIATION; OVARY CANCER; OVERALL SURVIVAL; PELVIS EXENTERATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNINEPHRECTOMY; URINARY DIVERSION; UTERINE CERVIX; UTERINE CERVIX CANCER; VAGINA CANCER; VULVECTOMY; WOUND DEHISCENCE; WOUND INFECTION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PELVIC EXENTERATION; POSTOPERATIVE COMPLICATIONS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 77950794334     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21518     Document Type: Article

References (27)

1. Morley GW, Hopkins MP, Lindenauer SM, et al.: Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 1989;74:934-943.
2. Lopez MJ, Petros JG, Augustinos P: Development and evolution of pelvic exenteration: Historical notes. Semin Surg Oncol 1999;17:147-151.
3. Sharma S, Odunsi K, Driscoll D, et al.: Pelvic exenterations for gynecological malignancies: Twenty-year experience at Roswell Park Cancer Institute. Int J Gynecol Cancer 2005;15:475-482. (Pubitemid 40705543)
4. Plante M, Roy M: The use of operative laparoscopy in determining eligibility for pelvic exenteration in patients with recurrent cervical cancer. Gynecol Oncol 1995;59:401-404.
5. Caceres A, Mourton SM, Bochner BH, et al.: Extended pelvic resections for recurrent uterine and cervical cancer: Out-of-thebox surgery. Int J Gynecol Cancer 2008;18:1139-1144.
6. Rutledge FN, Smith JP, Wharton JT, et al.: Pelvic exenteration: Analysis of 296 patients. Am J Obstet Gynecol 1977;129:881-892.
7. Goldberg GL, Sukumvanich P, Einstein MH, et al.: Total pelvic exenteration: The Albert Einstein College of Medicine/Monte- fiore Medical Center Experience (1987 to 2003). Gynecol Oncol 2006;101:261-268.
8. Minna JD, Higgins GA, Glatstein EJ: Cancer of the lung. In: De Vita V, Hellmann S, Rosenberg S, editors. Cancer: Principles and practice of oncology. Philadelphia, PA: Lippincott; 1984; p. 536.
9. Lopez MJ: Pelvic exenteration. In: Daly JM, Cady B, editors. Atlas of surgical oncology. Chicago: Mosby - Year Book; 1993; 555; 1994: 217-237.
10. Lopez MJ, Monafo WW: Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery 1993;113:365-372.
11. Spratt JS, Lopez MJ: Pelvic exenteration and illioguinal lymph node dissection. Surg Oncol Clin N Am 1994;3:217-237.
12. Weidemann H, Hieronimus-Reichel A, Sehouli J, et al.: Multivisceral surgery for advanced gynaecological malignancies. Eur Surg 2003;35:102-105. (Pubitemid 36549573)
13. Bricker EM: Bladder substitution after pelvic evisceration. Surg Clin North Am 1950;30:1511-1521.
14. Fotopoulou C, Neumann U, Klapp C, et al.: Long-term effects of neovaginal reconstruction with sigmoid loop technique on sexual function and self image in patients with gynecologic malignancies: Results of a prospective study. Gynecol Oncol 2008;111:400-406.
15. Geerts WH, Pineo GF, Heit J, et al.: Prevention of venous thromboembolism: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:338-400.
16. Ungar L, Palfalvi L, Novak Z: Primary pelvic exenteration in cervical cancer patients. Gynecol Oncol 2008;111:S9-S12.
17. Marnitz S, Köhler C, Müller M, et al.: Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol 2006;103:1023-1030. (Pubitemid 44821329)
18. Forner DM, Lampe B: Intestinal complications after pelvic exenterations in gynecologic oncology. Int J Gynecol Cancer 2009;19:958-962.
19. Chiva LM, Lapuente F, González-Cortijo L, et al.: Surgical treatment of recurrent cervical cancer: State of the art and new achievements. Gynecol Oncol 2008;110:S60-S66. [Epub Jul 21, 2008. Review].
20. Marnitz S, Dowdy S, Lanowska M, et al.: Exenterations 60 years after first description: Results of a survey among US and German Gynecologic Oncology Centers. Int J Gynecol Cancer 2009;19:974-977.
21. Maggioni A, Roviglione G, Landoni F, et al.: Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol 2009;114:64-68. [Epub May 2, 2009].
22. Berek JS, Howe C, Lagasse LD, et al.: Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol 2005;99:153-159. (Pubitemid 41354596)
23. Magrina JF, Stanhope CR, Weaver AL: Pelvic exenterations: Supralevator, infralevator, and with vulvectomy. Gynecol Oncol 1997;64:130-135.
24. Crozier M, Morris M, Levenback C, et al.: Pelvic exenteration for adenocarcinoma of the uterine cervix. Gynecol Oncol 1995;58:74-78.
25. Ferenschild FT, Vermaas M, Verhoef C, et al.: Total pelvic exenteration for primary and recurrent malignancies. World J Surg 2009;33:1502-1508.
26. Park JY, Choi HJ, Jeong SY, et al.: The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival. J Surg Oncol 2007;96:560-568.
27. Chiva LM, Lapuente F, Núñez C, et al.: Ileal orthotopic neobladder after pelvic exenteration for cervical cancer. Gynecol Oncol 2009;113:47-51. [Epub Jan 26, 2009].